Literature DB >> 26818873

Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery.

Xiao Hu, Fei-Fei Yang, Yong-Hong Liao1.   

Abstract

BACKGROUND: Systemic pulmonary delivery is considered to have advantages over oral or intravenous administration for certain drugs.
METHODS: In this article, we review the effects of intrinsic drug properties and drug loading carriers on the pharmacokinetic parameters of inhaled drugs in the context of use in systemic pulmonary delivery.
RESULTS: The delivery of drugs via inhalation can be advisable to achieve a fast onset of action; enhance the systemic bioavailability of drugs with poor oral absorption, including peptides and proteins; avoid invasive administration and improve patient compliance. To optimize the functioning of this delivery system, there is high demand for a systematic understanding of the pharmacokinetic characteristics, which are closely related to the pharmacodynamic and toxicological effects.
CONCLUSION: The pharmacokinetic parameters of inhaled drug products are affected by many factors, including physiological and pathological variables and the intrinsic drug and formulation properties.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26818873     DOI: 10.2174/1381612822666160128150005

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  2 in total

1.  Docetaxel-Loaded Cholesterol-PEG Co-Modified Poly (n-Butyl) Cyanoacrylate Nanoparticles for Antitumor Drug Pulmonary Delivery: Preparation, Characterization, and in vivo Evaluation.

Authors:  Xiao Hu; Feifei Yang; Yonghong Liao; Lin Li; Guoguang Zhao; Lan Zhang
Journal:  Int J Nanomedicine       Date:  2020-07-28

Review 2.  Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals.

Authors:  Fakhrossadat Emami; Alireza Vatanara; Eun Ji Park; Dong Hee Na
Journal:  Pharmaceutics       Date:  2018-08-17       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.